Roberto Iacovelli
Impact in
- Cancer Research top 1%
- Cancer Genomics and Diagnostics
- Pulmonary and Respiratory Medicine top 0.5%
- Renal cell carcinoma treatment
- Prostate Cancer Treatment and Research
Papers in
-
- Renal cell carcinoma treatment 94
- Prostate Cancer Treatment and Research 50
-
- Cancer Genomics and Diagnostics 50
- Co-authors
- Giampaolo TortoraChiara CiccareseEnrico CortesiMatteo SantoniAntonella PalazzoFilippo de BraudFrancesco MassariMaria Di Bartolomeo
- Journals
- Journal of Clinical Oncology (29 papers)Annals of Oncology (20 papers)Cancer Treatment Reviews (13 papers)Expert Review of Anticancer Therapy (9 papers)Critical Reviews in Oncology/Hematology (7 papers)
- Partner nations
- ItalyUnited StatesFrance
In The Last Decade
Roberto Iacovelli
210 papers receiving 4.5k citations
Hit Papers
Peers
Comparison fields: 5 of 109
- Cancer Research 1.2k
- Pulmonary and Respiratory Medicine 2.6k
- Oncology 2.1k
- Molecular Biology 1.5k
- Hepatology 172
Countries citing papers authored by Roberto Iacovelli
This map shows the geographic impact of Roberto Iacovelli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roberto Iacovelli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roberto Iacovelli more than expected).
Fields of papers citing papers by Roberto Iacovelli
This network shows the impact of papers produced by Roberto Iacovelli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roberto Iacovelli. The network helps show where Roberto Iacovelli may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Roberto Iacovelli, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 3 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 24 | |
| 6 | 2023 | 1 | |
| 7 | 2021 | 3 | |
| 8 | 2020 | 10 | |
| 9 | 2019 | 30 | |
| 10 | 2019 | 8 | |
| 11 | 2019 | 13 | |
| 12 | Cabazitaxel versus Abiraterone or Enzalutamide in Metastatic Prostate Cancer Hit paper breakdown → | 2019 | 377 |
| 13 | 2018 | 12 | |
| 14 | 2018 | 2 | |
| 15 | 2018 | 4 | |
| 16 | LC3B and ph-S6K are both expressed in epithelioid and classic renal angiomyolipoma: a rationale tissue-based evidence for combining use of autophagic and mTOR targeted drugs | 2016 | 1 |
| 17 | 2016 | 10 | |
| 18 | 2015 | 4 | |
| 19 | 2014 | 3 | |
| 20 | 2007 | 1 |
About Roberto Iacovelli
Roberto Iacovelli is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research, Oncology, Radiology, Nuclear Medicine and Imaging and Hematology, having authored 224 papers that have together received 4.6k indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (94 papers), Cancer Genomics and Diagnostics (50 papers), Prostate Cancer Treatment and Research (50 papers), Cancer Immunotherapy and Biomarkers (41 papers), Renal and related cancers (35 papers), Bladder and Urothelial Cancer Treatments (30 papers), Radiopharmaceutical Chemistry and Applications (21 papers) and Pancreatic and Hepatic Oncology Research (16 papers). The work is most often cited by research in Cancer Research (1.2k citations), Pulmonary and Respiratory Medicine (2.6k citations), Oncology (2.1k citations), Molecular Biology (1.5k citations) and Hepatology (172 citations). Roberto Iacovelli has collaborated with scholars based in Italy, United States and France. Frequent co-authors include Giampaolo Tortora, Chiara Ciccarese, Enrico Cortesi, Matteo Santoni, Antonella Palazzo, Filippo de Braud, Francesco Massari, Maria Di Bartolomeo, Filippo Pietrantonio and Claudia Maggi. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Cancer Treatment Reviews, Expert Review of Anticancer Therapy and Critical Reviews in Oncology/Hematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.